US Stock MarketDetailed Quotes
RCEL Avita Medical
- 12.870
- -0.180-1.38%
Close Nov 21 16:00 ET
- 12.870
- 0.0000.00%
Post 16:20 ET
337.42MMarket Cap-5771P/E (TTM)
13.450High12.580Low120.10KVolume13.180Open13.050Pre Close1.56MTurnover0.51%Turnover RatioLossP/E (Static)26.22MShares18.93052wk High27.62P/B300.66MFloat Cap7.51052wk Low--Dividend TTM23.36MShs Float55.350Historical High--Div YieldTTM6.67%Amplitude4.410Historical Low13.025Avg Price1Lot Size
About Avita Medical Company
AVITA Medical, Inc., through its subsidiaries, engages in the development and commercialization of a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs. Its product, RECELL system, is a device that enables healthcare professionals to produce a suspension of spray-on skin cells using a small sample of the patient's own skin for the treatment of acute thermal burns. The company was founded in December 1992 and is headquartered in Valencia, CA.
Company Profile
SymbolRCEL
Company NameAvita Medical
Listing DateOct 1, 2019
Founded2020
CEOMr. James M. Corbett
MarketNASDAQ
Employees207
Fiscal Year Ends12-31
Address28159 Avenue Stanford,Suite 220
CityValencia
ProvinceCalifornia
CountryUnited States of America
Zip Code91355
Phone1-833-462-8482
Websitehttp://www.avitamedical.com
Company Executives
- Name
- Position
- Salary
- James M. Corbett
- Director, Chief Executive Officer and President
- 73.54K
- David O’Toole
- Chief Financial Officer and Principal Accounting Officer
- --
- Nicole Kelsey
- Chief Legal and Compliance Officer and Corporate Secretary
- --
- Louis J. Panaccio
- Chairman of the Board
- 244.99K
- Jan Stern Reed
- Independent Director
- 211.24K
- Professor Suzanne Crowe
- Independent Director
- 213.74K
- Robert E. Mcnamara
- Independent Director
- --
- Jeremy L. Curnock Cook
- Independent Director
- 209.58K
- Cary G. Vance
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data